Application of fFN and CRP in the evaluation of therapeutic effect for preterm labor.
- Author:
Rui LI
- Publication Type:Journal Article
- MeSH:
C-Reactive Protein;
analysis;
Female;
Fibronectins;
blood;
Humans;
Infant, Newborn;
Obstetric Labor, Premature;
diagnosis;
prevention & control;
Pregnancy
- From:
Chinese Journal of Medical Instrumentation
2015;39(1):77-78
- CountryChina
- Language:Chinese
-
Abstract:
Select 106 pregnant women with threatened preterm labor between 28 and 37 weeks of gestation. They have been treated continually by the preventing preterm labor therapy including antibiotics and magnesium sulfate. Cervicovaginal fetal fibronectin (fFN) and C-reactive protein (CRP) in serum were detected before treatment and after 3-day and 7-day treatment respectively. 100 normal pregnant women were included as control group. (1) The fFN and CRP had significant differences between study group and control group (P<0.05). (2) The fFN and CPR were different compared in the treatment period (P<0.05). Fetal fibronectin and CRP can be used can be used in therapeutic effect evaluation of threatened preterm labor.
